Get your online CPR Certification & Training, life saving course!

ACLS Cases – Tachycardia Stable and Unstable

  • Tachycardia is a heart rate greater than 100 bpm
  • Symptoms usually start to emerge at heart rates > 150 bpm
  • The first goal is to determine whether tachycardiais stable or unstable
    • Stable tachycardia is tachycardia that does not cause symptoms
    • Unstable tachycardia is tachycardia that causes symptoms

 

  • Symptomatic (unstable) tachycardia includes:
    • Altered mental status
    • Chest discomfort
    • Signs of shock
    • Hypotension
    • Acute heart failure
  • Synchronized cardioversion
    • Atrial fibrillation: 120 J to 200 J biphasic or 200 J monophasic
    • Unstable supraventricular tachycardia: 50 J to 100 Jmonophasic
    • Unstable atrial flutter: 50 J to 100 J monophasic
    • Monomorphic VTach: 100 J monophasic
    • Unstable VTach: 200 J monophasic
    • Narrow regular: 50 J to 100 J
    • Narrow irregular: 120 J to 200 J biphasic or 200 J monophasic
    • Wide regular: 100 J monophasic
    • Polymorphic irregular: Defibrillation dose (unsynchronized)
    • Wide irregular: Defibrillation dose (unsynchronized)

 

Be prepared to move to VTach/VFib pathway if patient enters cardiac arrest!

 

Stable Tachycardia Management

  • Get 12-lead ECG
    • Is the QRS complex narrow or wide?
    • Is the rhythm regular or irregular?
    • Is the rhythm sinus tachycardia?
  • Narrow complex, stable tachycardia
    • Vagal maneuvers
    • Adenosine
      • 6 mg IV first dose
      • 12 mg IV second dose
  • Wide QRS complex, regular and monomorphic, stable tachycardia
    • Consider adenosine or anti-arrhythmic infusion
    • Consider anti-arrhythmic infusion
      • Amiodarone
        • first dose: 150 mg over 10 minutes
        • Repeat if VTach recurs
        • Maintenance infusion: 1 mg/min for 6 hours
      • Procainamide
        • 20-50 mg/min
        • Maintenance infusion: 1-4 mg/min
        • Do not use if QT prolongation or CHF present
      • Sotalol
        • 100 mg (1.5 mg/kg) over 5 min
        • Do not use in people with prolonged QT
  • Consider expert consultation
  • Wide complex, polymorphic tachycardia
    • Consider anti-arrhythmic infusion
    • Expert consultation

If any stable tachycardia deteriorates to unstable tachycardia or is resistant to other treatments, administer synchronized cardioversion

Nationwide Health Training © 2023

Location: Nationwide Health Training, 3240 118th Ave SE, Unit #100, Bellevue, WA 98005